Regulatory Roles of the Gut Microbiota in Hematological Malignancies

Relying on the proposed gut–bone marrow bidirectional regulatory axis, the gut microbiota may influence systemic immune homeostasis and the bone marrow hematopoietic microenvironment through maintenance of the mucosal barrier and signaling molecules such as short-chain fatty acids and tryptophan metabolites, and may thereby contribute to the pathobiology of hematological malignancies. Patients with hematological malignancies often exhibit dysbiosis, including decreased gut microbial diversity, the depletion of butyrate-producing beneficial bacteria, and the overproliferation of opportunistic pathogens, although patterns vary across cohorts. This dysbiosis may contribute to malignant clonal expansion and disease progression and has been associated with variation in the response to chemotherapy and cellular therapy and with the risk of graft-versus-host disease, severe infections, and intestinal mucositis following allogeneic hematopoietic stem cell transplantation. This narrative review summarizes interactions between the gut microbiota and hematological malignancies, disease-associated microbiota profiles, treatment-related associations, and barriers to clinical translation. Because much of the human evidence is observational, microbiota-directed interventions require prospective validation before routine clinical use.

Authors

Publication Details

Journal
International Journal of Molecular Sciences
Published
2026-11-18
DOI
https://doi.org/10.3390/ijms272210377
Primary Topic
Gut microbiota and health
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Regulatory Roles of the Gut Microbiota in Hematological Malignancies

Xiaoxuan Liu, Zhi Guo
2 links
International Journal of Molecular Sciences
Gut microbiota and health
article

Regulatory Roles of the Gut Microbiota in Hematological Malignancies

Xiaoxuan Liu, Zhi Guo
article en

Abstract

Relying on the proposed gut–bone marrow bidirectional regulatory axis, the gut microbiota may influence systemic immune homeostasis and the bone marrow hematopoietic microenvironment through maintenance of the mucosal barrier and signaling molecules such as short-chain fatty acids and tryptophan metabolites, and may thereby contribute to the pathobiology of hematological malignancies. Patients with hematological malignancies often exhibit dysbiosis, including decreased gut microbial diversity, the depletion of butyrate-producing beneficial bacteria, and the overproliferation of opportunistic pathogens, although patterns vary across cohorts. This dysbiosis may contribute to malignant clonal expansion and disease progression and has been associated with variation in the response to chemotherapy and cellular therapy and with the risk of graft-versus-host disease, severe infections, and intestinal mucositis following allogeneic hematopoietic stem cell transplantation. This narrative review summarizes interactions between the gut microbiota and hematological malignancies, disease-associated microbiota profiles, treatment-related associations, and barriers to clinical translation. Because much of the human evidence is observational, microbiota-directed interventions require prospective validation before routine clinical use.

International Journal of Molecular SciencesVol. 27(22)
Good health and well-being
Gut microbiota and health
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon